Cytological, molecular-genetic, and biochemical studies of buccal epithelium in individuals with a neurodegenerative disease ‒ Alzheimer’s disease (systematic review)

 

Authors

 

V.V. Bazarnyy

Federal State Budgetary Educational Institution of Higher Education “Ural State Medical University” of the Ministry of Health of the Russian Federation, Yekaterinburg, Russian Federation

A.A. Melnik

Federal State Budgetary Educational Institution of Higher Education “Ural State Medical University” of the Ministry of Health of the Russian Federation, Yekaterinburg, Russian Federation

K.P. Dik

Federal State Budgetary Educational Institution of Higher Education “Ural State Medical University” of the Ministry of Health of the Russian Federation, Yekaterinburg, Russian Federation

A.P. Sidenkova

Federal State Budgetary Educational Institution of Higher Education “Ural State Medical University” of the Ministry of Health of the Russian Federation, Yekaterinburg, Russian Federation

 

https://doi.org/10.26617/1810-3111-2026-3(132)-112-129

 

Journal: Siberian Herald of Psychiatry and Addiction Psychiatry. 2026; 3 (132):  112-129.

 

Abstract

Introduction. Proteomic P research findings indicate the expression of pathological proteins typical for neurodegenerative diseases in peripheral tissues. Tissues sharing a common embryonic origin with the brain—such as those of the epidermal-type epithelium ‒ can serve as subjects for study of neurodegenerative processes. The epithelium of the inner cheek mucosa (buccal epithelium) is accessible for exfoliative cytology. Objective. To summarize published results from cytological, biochemical, and molecular-genetic laboratory studies of the buccal epithelium in patients with Alzheimer’s disease. Materials and Methods. Scientific publications available in the eLibrary.ru and PubMed databases. Search date: January 2026. The search on eLibrary.ru used the keywords: biomarkers, buccal epithelium, Alzheimer’s disease. PubMed searches used the following keyword combinations: biomarkers, buccal cells, Alzheimer’s disease; oral mucosal epithelium, biomarkers, Alzheimer’s disease; oral mucosa, Alzheimer’s disease; oral epithelium, Alzheimer's disease; buccal cavity cells, oral cavity cells, Alzheimer's disease. This review included 20 comparative studies selected based on the criteria of methodology, representativeness, objectivity, applicability of results, and comprehensiveness of conclusions. Research findings indicated an increased frequency of cytological abnormalities, altered expression of amyloid and hyperphosphorylated p-tau, telomere shortening, and other changes in the buccal epithelial cells of patients with Alzheimer’s disease and mild cognitive impairment (MCI). Proteomic studies of various peripheral tissues, including buccal epithelium, provide a reliable source of material with a stable molecular structure; this enhances their diagnostic potential, grounded in a conceptual approach to the disease as a systemic proteinopathy.

 

Keywords: biomarkers, buccal epithelium, Alzheimer’s disease, proteinopathy, proteomics.

 

Article (pdf)

 

Contacts

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Materials  

For citation: Bazarnyy V.V., Melnik A.A., Dik K.P., Sidenkova A.P. Cytological, molecular-genetic, and biochemical studies of buccal epithelium in individuals with a neurodegenerative disease ‒ Alzheimer’s disease (systematic review). Siberian Herald of Psychiatry and Addiction Psychiatry.2026; 3 (132): 112-129. https://doi.org/10.26617/1810-3111-2026-3(132)-112-129

 

REFERENCES

  1. Gustavsson A, Norton N, Fast T, Frölich L, Georges J, Holzapfel D, Kirabali T, Krolak-Salmon P, Rossini PM, Ferretti MT, Lanman L, Santuccione Chadha A, van der Flier WM. Global estimates on the number of persons across the Alzheimer’s disease continuum. Alzheimer’s Dement. 2023 Feb;19(2):658-670. https://doi.org/10.1002/alz.12694. Epub 2022 Jun 2. PMID: 35652476.
  2. Alzheimer’sAssociation. 2013 Alzheimer’s disease facts and figures. Alzheimer’s Dement.2013 Mar;9(2):208-45. https://doi.org/10.1016/j.jalz.2013.02.003.PMID: 23507120.
  3. Lau SF, Wu W, Wong HY, Ouyang L, Qiao Y, Xu J, Lau JH, Wong C, Jiang Y, Holtzman DM, Fu AKY, Ip NY. The VCAM1-ApoE pathway directs microglial chemotaxis and alleviates Alzheimer’s disease pathology. Nat Aging. 2023 Oct;3(10):1219-1236. https://doi.org/10.1038/s43587-023-00491-1. Epub 2023 Sep 21. PMID: 37735240; PMCID: PMC10570140.
  4. Morris JK, Honea RA, Vidoni ED, Swerdlow RH, Burns JM. Is Alzheimer’s disease a systemic disease? Biochim Biophys Acta. 2014 Sep;1842(9):1340-9. https://doi.org/10.1016/j.bbadis.2014.04.012.Epub 2014 Apr 18. PMID: 24747741; PMCID: PMC4126236.
  5. Floden AM, Sohrabi M, Nookala S, Cao JJ, Combs CK. Salivary Aβ Secretion and Altered Oral Microbiome in Mouse Models of AD. Curr Alzheimer Res. 2020;17(12):1133-1144.https://doi.org/10.2174/1567205018666210119151952.PMID: 33463464; PMCID: PMC8122496.
  6. Jain M, Dhariwal R, Patil N, Ojha S, Tendulkar R, Tendulkar M, Dhanda PS, Yadav A, Kaushik P. Unveiling the molecular footprint: Proteome-based biomarkers for Alzheimer’s disease. Proteomes. 2023 Oct 16;11(4):33.https://doi.org/10.3390/proteomes11040033. PMID: 37873875; PMCID: PMC10594437.
  7. Ai X, Cao Z, Ma Z, Liu Q, Huang W, Sun T, Li J, Yang C. Proteomic analysis reveals physiological activities of aβ peptide for Alzheimer’sdisease. Int J Mol Sci. 2024 Jul 30;25(15):8336. https://doi.org/10.3390/ijms25158336. PMID: 39125907; PMCID: PMC11313142.
  8. Liao C, Xu J, Chen Y, Ip NY. Retinal dysfunction in Alzheimer’s disease and implications for biomarkers. Biomolecules. 2021 Aug 16;11(8):1215. https://doi.org/10.3390/biom11081215. PMID: 34439882; PMCID: PMC8394950.
  9. Toyli A, Shaik A, Zhao C, Chen QH, Sha Q, Zhou W. The heart-brain axis: unraveling the interconnections between cardiovascular and Alzheimer’sdiseases. Front Cardiovasc Med. 2025 Nov 24;12:1685461.https://doi.org/10.3389/fcvm.2025.1685461. PMID: 41367378; PMCID: PMC12682763.
  10. Romani M, Sorrentino V, Oh CM, Li H, de Lima TI, Zhang H, Shong M, Auwerx J. NAD+ boosting reduces age-associated amyloidosis and restores mitochondrial homeostasis in muscle. Cell Rep. 2021 Jan 19;34(3):108660.https://doi.org/10.1016/j.celrep.2020.108660. PMID: 33472069; PMCID: PMC7816122.
  11. Ullah R, Lee EJ. Advances in amyloid-β clearance in the brain and periphery: Implications for neurodegenerative diseases. Exp Neurobiol. 2023 Aug 31;32(4):216-246. https://doi.org/10.5607/en23014. PMID: 37749925; PMCID: PMC10569141.
  12. Wu T, Chen L, Zhou L, Xu J, Guo K. Platelets transport β-amyloid from the peripheral blood into the brain by destroying the blood-brain barrier to accelerate the process of Alzheimer’sdisease in mouse models. Aging (Albany NY). 2021 Mar 5;13(5):7644-7659.https://doi.org/10.18632/aging.202662. Epub 2021 Mar 5. PMID: 33668038; PMCID: PMC7993748.
  13. Kulichikhin KY, Malikova OA, Zobnina AE, Zalutskaya NM, Rubel AA. Interaction of proteins involved in neuronal proteinopathies. Life (Basel). 2023 Sep 23;13(10):1954.https://doi.org/10.3390/life13101954. PMID: 37895336; PMCID: PMC10608209.
  14. Yang J, Zhi W, Wang L. Role of tau protein in neurodegenerative diseases and development of its targeted drugs: A literature review. Molecules. 2024 Jun 13;29(12):2812.https://doi.org/10.3390/molecules29122812. PMID: 38930877; PMCID: PMC11206543.
  15. Li W, Li HL, Wang JZ, Liu R, Wang X. Abnormal protein post-translational modifications induces aggregation and abnormal deposition of protein, mediating neurodegenerative diseases. Cell Biosci. 2024 Feb 12;14(1):22. https://doi.org/10.1186/s13578-023-01189-y. PMID: 38347638; PMCID: PMC10863199.
  16. Marquez A, Guernsey LS, Frizzi KE, Cundiff M, Constantino I, Muttalib N, Arenas F, Zhou X, Lim SH, Ferdousi M, Ponirakis G, Silverdale M, Kobylecki C, Jones M, Marshall A, Malik RA, Jolivalt CG. Tau associated peripheral and central neurodegeneration: Identification of an early imaging marker for tauopathy. Neurobiol Dis. 2021 Apr;151:105273.https://doi.org/10.1016/j.nbd.2021.105273. Epub 2021 Jan 19. PMID: 33482356; PMCID: PMC7925437.
  17. Vacchi E, Lazzarini E, Pinton S, Chiaro G, Disanto G, Marchi F, Robert T, Staedler C, Galati S, Gobbi C, Barile L, Kaelin-Lang A, Melli G. Tau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathies. Brain. 2022 Aug 27;145(8):2755-2768.https://doi.org/10.1093/brain/awac161. PMID: 35485527.
  18. Corsini NS, Knoblich JA. Human organoids: New strategies and methods for analyzing human development and disease. Cell. 2022 Jul 21;185(15):2756-2769. https://doi.org/10.1016/j.cell.2022.06.051. PMID: 35868278.
  19. Xu B, Lei X, Yang Y, Yu J, Chen J, Xu Z, Ye K, Zhang J. Peripheral proteinopathy in neurodegenerative diseases. Transl Neurodegener. 2025 Jan 16;14(1):2. https://doi.org/10.1186/s40035-024-00461-6. PMID: 39819742; PMCID: PMC11737199.
  20. Wu Y, Ma B, Liu C, Li D, Sui G. Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases. Int J Mol Sci. 2024 Sep 23;25(18):10187.https://doi.org/10.3390/ijms251810187. PMID: 39337671; PMCID: PMC11432175.
  21. Xie J, Gorlé N, Vandendriessche C, Van Imschoot G, Van Wonterghem E, Van Cauwenberghe C, Parthoens E, Van Hamme E, Lippens S, Van Hoecke L, Vandenbroucke RE. Low-grade peripheral inflammation affects brain pathology in the AppNL-G-Fmouse model of Alzheimer’s disease. Acta Neuropathol Commun. 2021 Oct 7;9(1):163. https://doi.org/10.1186/s40478-021-01253-z. PMID: 34620254; PMCID: PMC8499584.
  22. Koszła O, Sołek P. Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways. Cell Commun Signal. 2024 Aug 30;22(1):421. https://doi.org/10.1186/s12964-024-01791-8. PMID: 39215343; PMCID: PMC11365204.
  23. Pils M, Dybala A, Schaffrath A, Rehn F, Kutzsche J, Blömeke L, Tusche M, Özdüzenciler P, Bujnicki T, Kraemer-Schulien V, Gramespacher H, Schmieschek MHT, Barbe MT, Onur OA, Fink GR, Tamgüney G, Bannach O, Willbold D. Elevated Aβ aggregates in feces from Alzheimer’s disease patients: a proof-of-concept study. Alzheimers Res Ther. 2024 Oct 14;16(1):223. https://doi.org/10.1186/s13195-024-01597-3. PMID: 39402637; PMCID: PMC11472473.
  24. Bayer TA. Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders? Eur Neuropsychopharmacol. 2015 May;25(5):713-24.https://doi.org/10.1016/j.euroneuro.2013.03.007. Epub 2013 May 1. PMID: 23642796.
  25. Lazarev VF, Alhasan BA, Guzhova IV, Margulis BA. "Proteinjury": a universal pathological mechanism mediated by cerebrospinal fluid in neurodegeneration and trauma. Front Cell Dev Biol. 2025 May 20;13:1593122.https://doi.org/10.3389/fcell.2025.1593122. PMID: 40463840; PMCID: PMC12130017.
  26. Ochneva A, Zorkina Y, Abramova O, Pavlova O, Ushakova V, Morozova A, Zubkov E, Pavlov K, Gurina O, Chekhonin V. Protein misfolding and aggregation in the brain: common pathogenetic pathways in neurodegenerative and mental disorders. Int J Mol Sci. 2022 Nov 21;23(22):14498. https://doi.org/10.3390/ijms232214498. PMID: 36430976; PMCID: PMC9695177.
  27. Schaich CL, Maurer MS, Nadkarni NK. Amyloidosis of the brain and heart: Two sides of the same coin? JACC Heart Fail. 2019 Feb;7(2):129-131. https://doi.org/10.1016/j.jchf.2018.12.014. PMID: 30704604; PMCID: PMC6515925.
  28. Rallis E, Grech VS, Lotsaris K, Tertipi N, Sfyri E, Kefala V. Skin and induced pluripotent stem cells as biomarkers for neurodegenerative diseases. Genes (Basel). 2024 Nov 25;15(12):1507.https://doi.org/10.3390/genes15121507. PMID: 39766775; PMCID: PMC11675334.
  29. Hochuli AHD, Senegaglia AC, Selenko AH, Fracaro L, Brofman PRS. Dental pulp from human exfoliated deciduous teeth-derived stromal cells demonstrated neuronal potential: In vivo and in vitro studies. Curr Stem Cell Res Ther. 2021;16(5):495-506.https://doi.org/10.2174/1574888X16666210215160402.PMID: 33588741.
  30. Klostermeier S, Li A, Hou HX, Green U, Lennerz JK. Exploring the skin brain link: Biomarkers in the skin with implications for aging research and Alzheimer’s disease diagnostics. Int J Mol Sci. 2023 Aug 28;24(17):13309.https://doi.org/10.3390/ijms241713309. PMID: 37686115; PMCID: PMC10487444.
  31. Bazarnyi VV, Mandra YV, Sidenkova AP, Polushina LG, Maksimova AY, Sementsova EA, Svetlakova EN, Nasretdinova NY, Kotikova AY. Age features of buccal epithelium in practically healthy people. Klin Lab Diagn. 2022 Jun 20;67(6):345-349. English. https://doi.org/10.51620/0869-2084-2022-67-6-345-349. PMID: 35749599.
  32. Myakotnykh VS, Sidenkova AP, Kharitonova MP, Meshchaninov VN, Melnik AA, Khilyuk DA. The state of the oral cavity in early diagnosis and predicting cognitive disorders. Adv Gerontol. 2022;35(3):418-428. PMID: 36169371 (in Russian).
  33. Shetty DC, Wadhwan V, Khanna KS, Jain A, Gupta A. Exfoliative cytology: A possible tool in age estimation in forensic odontology. J Forensic Dent Sci. 2015 Jan-Apr;7(1):63-6. https://doi.org/10.4103/0975-1475.150321. PMID: 25709323; PMCID: PMC4330622.
  34. Arredondo LF, Aranda-Romo S, Rodríguez-Leyva I, Chi-Ahumada E, Saikaly SK, Portales-Pérez DP, González-Amaro R, Salgado-Bustamante M, Enriquez-Macias L, Eng W, Norman RA, Jimenez-Capdeville ME. Tau Protein in oral mucosa and cognitive state: A cross-sectional study. Front Neurol. 2017 Oct 13;8:554.https://doi.org/10.3389/fneur.2017.00554. PMID: 29081764; PMCID: PMC5645496.
  35. Hattori H, Matsumoto M, Iwai K, Tsuchiya H, Miyauchi E, Takasaki M, Kamino K, Munehira J, Kimura Y, Kawanishi K, Hoshino T, Murai H, Ogata H, Maruyama H, Yoshida H. The tau protein of oral epithelium increases in Alzheimer’s disease. J Gerontol A Biol Sci Med Sci. 2002 Jan;57(1):M64-M70. https://doi.org/10.1093/gerona/57.1.m64.
  36. Thomas P, Hecker J, Faunt J, Fenech M. Buccal micronucleus cytome biomarkers may be associated with Alzheimer's disease. Mutagenesis. 2007 Nov;22(6):371-9. https://doi.org/10.1093/mutage/gem029. Epub 2007 Aug 20. PMID: 17709794.
  37. Thomas P, O’Callaghan NJ, Fenech M. Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease. Mech Ageing Dev. 2008 Apr;129(4):Alzheimer’s disease. Mech Ageing Dev. 2008 Apr;129(4):183-90.https://doi.org/10.1016/j.mad.2007.12.004.
  38. de Oliveira RM, Lia EN, Guimarães RM, Bocca AL, Cavalcante Neto FF, da Silva TA. Cytologic and cytometric analysis of oral mucosa in Alzheimer’s disease. Anal Quant Cytol Histol. 2008 Apr;30(2):113-8. PMID: 18561748
  39. Mathur S, Glogowska A, McAvoy E, Righolt C, Rutherford J, Willing C, Banik U, Ruthirakuhan M, Mai S, Garcia A. Three-dimensional quantitative imaging of telomeres in buccal cells identifies mild, moderate, and severe Alzheimer’s disease patients. J Alzheimers Dis. 2014;39(1):35-48. https://doi.org/10.3233/JAD-130866.
  40. François M, Leifert W, Hecker J, Faunt J, Martins R, Thomas P, Fenech M. Altered cytological parameters in buccal cells from individuals with mild cognitive impairment and Alzheimer’s disease. Cytometry A. 2014 Aug;85(8):698-708. https://doi.org/10.1002/cyto.a.22453.
  41. Thomas P, Fenech M. Buccal cytome biomarkers and their association with plasma folate, vitamin B12 and homocysteine in Alzheimer’s Disease. J Nutrigenet Nutrigenomics. 2015;8(2):57-69.https://doi.org/10.1159/000435784.
  42. Leifert WR, Nguyen T, Rembach A, Martins R, Rainey-Smith S, Masters CL, Ames D, Rowe CC, Macaulay SL, François M, Fenech MF; Australian Imaging, Biomarkers and Lifestyle Study Research Group. Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer’s Disease Risk. J Alzheimers Dis. 2015;48(2):443-52. https://doi.org/10.3233/JAD-150330. PMID: 26402008/
  43. Leifert WR, Tuli JF, Francois M, Nguyen T, Rembach A, Rumble RL, Rainey-Smith S, Martins R, Fenech MF. Buccal cell cytokeratin 14 identifies mild cognitive impairment and Alzheimer' s disease in the AIBL study of aging. Curr Alzheimer Res. 2015;12(3):233-41. https://doi.org/10.2174/1567205012666150302154650. PMID: 25731627.
  44. François M, Fenech MF, Thomas P, Hor M, Rembach A, Martins RN, Rainey-Smith SR, Masters CL, Ames D, Rowe CC, Macaulay SL, Hill AF, Leifert WR, The Australian Imaging Biomarkers And Lifestyle Study Research Group. High content, multi-parameter analyses in buccal cells to identify Alzheimer’s disease.. Curr Alzheimer Res. 2016;13(7):787-99.https://doi.org/10.2174/1567205013666160315112151.PMID:26975368.
  45. Garcia A, Huang D, Righolt A, Righolt C, Kalaw MC, Mathur S, McAvoy E, Anderson J, Luedke A, Itorralba J, Mai S. Super-resolution structure of DNA significantly differs in buccal cells of controls and Alzheimer’s patients. J Cell Physiol. 2017;232(9):2387-2395. https://doi.org/10.1002/jcp.25751
  46. Garcia A, Mathur S, Kalaw MC, et al. Quantitative 3D Telomeric Imaging of Buccal Cells Reveals Alzheimer’s Disease-Specific Signatures. Journal of Alzheimer’s Disease. 2017;58(1):139-145. https://doi.org/10.3233/JAD-161169.
  47. Zuev VA, Linkova NS, Polyakova VO, Paltseva EM, Kvetnaya TV, Kukanova EO, Popuchiev VV. Aβ42 – a promising non-invasive marker for the intravital diagnosis of Alzheimer’s disease. Molecular Medicine. 2017;15(1):24-27 (in Russian).
  48. Arredondo LF, Aranda-Romo S, Rodríguez-Leyva I, Chi-Ahumada E, Saikaly SK, Portales-Pérez DP, González-Amaro R, Salgado-Bustamante M, Enriquez-Macias L, Eng W, Norman RA, Jimenez-Capdeville ME. Tau protein in oral mucosa and cognitive state: A cross-sectional study. Front Neurol. 2017 Oct 13;8:554. https://doi.org/10.3389/fneur.2017.00554. PMID: 29081764; PMCID: PMC5645496.
  49. Kose Ozlece H, Findik Guvendi G, Huseyinoglu N, Ehi Y, Kivrak Y. Cytological and cytometric analysis of oral mucosa in patients with Alzheimer’s and Parkinson Alzheimer’s disease. Neuropsychiatr Dis Treat. 2018;14:1901–1906.https://doi.org/10.2147/NDT.S157731.
  50. Zuev VA, Dyatlova AS, Lin’kova NS, Kvetnaya TV. Expression of Aβ42, τ-Protein, p16, p53 in buccal epithelium: Prospects for use in the diagnostics of Alzheimer’s disease and rate of aging. Bull Exp Biol Med. 2019;166(5):676–679.https://doi.org/10.1007/s10517-019-04416-0.
  51. Siddiqui MS, Francois M, Rainey-Smith S, Martins R, Masters CL, Ames D, Rowe CC, Macaulay LS, Fenech MF, Leifert WR. Evaluation of gammaH2AX in buccal cells as a molecular biomarker of DNA damage in Alzheimer’s disease in the AIBL study of ageing. Life (Basel). 2020;10(8):141. https://doi.org/10.3390/life10080141.
  52. Reimann H, Stopper H, Polak T, Lauer M, Herrmann MJ, Deckert J, Hintzsche H. Micronucleus frequency in buccal mucosa cells of patients with neurodegenerative diseases. Sci Rep. 2020 Dec 17;10(1):22196. https://doi.org/10.1038/s41598-020-78832-y. PMID: 33335130; PMCID: PMC7747561.
  53. Bazarny VV, Sidenkova AP, Rezaykin AV, Myakotnykh VS, Borovkova TA, Selkina EO, Polushina LG, Maksimova AYu, Vankova EA. The possibility of using the results of the study of oral fluid and buccal epithelium in the diagnosis of Alzheimer’s disease. Advances in Gerontology. 2021;34(4):550-557. https://doi.org/10.34922/AE.2021.34.4.007 (in Russian).
  54. Paraskevaidi M., Karim S., Santos M, Lima K, Crean, S. The use of ATR-FTIR spectroscopy for the diagnosis of Alzheimer’s disease using oral buccal cells. Applied Spectroscopy Review. 2023. November;59(8):1021-1035. https://doi.org/10.1080/05704928.2023.2284283.
  55. Grech VS, Lotsaris K, Kefala V, Rallis E. From skin to brain: Key genetic mediators. Associating Cutaneous Inflammation and Neurodegenerative Diseases. Genes. 2025; 16(12):1463.https://doi.org/10.3390/genes16121463.
  56. Rehman B, Muzio MR. Embryology, Week 2-3. 2023 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
  57. Li X, Kiprowska M, Kansara T, Kansara P, Li P. Neuroinflammation: A distal consequence of periodontitis. J Dent Res. 2022 Nov;101(12):1441-1449. https://doi.org/10.1177/00220345221102084.
  58. Eslami M, Alibabaei F, Babaeizad A, Banihashemian SZ, Mazandarani M, Hoseini A, Ramezankhah M, Oksenych V, Yousefi B. The importance of gut microbiota on choline metabolism in neurodegenerative diseases. Biomolecules. 2024 Oct 23;14(11):1345. https://doi.org/10.3390/biom14111345.
  59. Paltsev MA, Zuev VA, Kozhevnikova EO, Linkova NS, Kvetnaia TV, Polyakova VO, Kvetnoy IM. Molecular markers of Alzheimer disease early diagnostic: investigation perspectives of peripheral tissues. AdvGerontol. 2017;30(6):809-817. PMID: 29608821(in Russian).
  60. Zhang X, Zhong M, Li Y, Wang H, Xi G, Wang F, Cheng C, Shi Y. Oral microbiota and central nervous system diseases: A review. Neuroprotection. 2025 Feb 9;3(1):79-94. https://doi.org/10.1002/nep3.75.
  61. François M, Leifert W, Martins R, Thomas P, Fenech M. Biomarkers of Alzheimer’s disease risk in peripheral tissues; focus on buccal cells. Curr Alzheimer Res. 2014;11(6):519-31.https://doi.org/10.2174/1567205011666140618103827. PMID: 24938500; PMCID: PMC4166904.
  62. Migliore L, Coppedè F, Fenech M, Thomas P. Association of micronucleus frequency with neurodegenerative diseases. Mutagenesis. 2011;26(1):85-92. https://doi.org/10.1093/mutage/geq067
  63. Dubois B, von Arnim CAF, Burnie N, Bozeat S, Cummings J. Biomarkers in Alzheimer’s disease: role in early and differential diagnosis and recognition of atypical variants. AlzheimersResTher. 2023 Oct 13;15(1):175. https://doi.org/10.1186/s13195-023-01314-6.
  64. Bolognesi C, Bonassi S, Knasmueller S, Fenech M, Bruzzone M, Lando C, Ceppi M. Clinical application of micronucleus test in exfoliated buccal cells: A systematic review and metanalysis. Mutat Res Rev Mutat Res. 2015;766:20–31.https://doi.org/10.1016/j.mrrev.2015.07.002.
  65. Bentz K, Molcanyi M, Hess S, Schneider A, Hescheler J, Neugebauer E, Schaefer U. Neural differentiation of embryonic stem cells is induced by signalling from non-neural niche cells. Cell PhysiolBiochem. 2006;18(4-5):275-86. https://doi.org/10.1159/000097674.
  66. Altman DG, Bland JM. Diagnostic tests. 1: sensitivity and specificity. BMJ.1994 308 (6943): 1552. https://doi.org/10.1136/bmj.308.6943.1552.
  67. Paltsev MA, Zuev VA, Kozhevnikova EO, Linkova NS, Kvetnaia TV, Polyakova VO, Kvetnoy IM. Molecular markers for the early diagnosis of Alzheimer’s disease: prospects for research in peripheral tissues. Advances in Gerontology. 2018;8(2):111-118. https://doi.org/10.1134/S2079057018020133 (in Russian).
  68. Si Z, Sun L, Wang X. Evidence and perspectives of cell senescence in neurodegenerative diseases. Biomed Pharmacother. 2021 May;137:111327. https://doi.org/10.1016/j.biopha.2021.111327.
  69. Paraskevaidi M, Allsop D, Karim S, Martin FL, Crean S. Diagnostic biomarkers for Alzheimer’s disease using non-invasive specimens. J Clin Med. 2020;9(6):1673. https://doi.org/10.3390/jcm9061673.
  70. Avramouli A, Vlamos P. Buccal mucosa biomarkers in Alzheimer’s disease. AdvExp Med Biol. 2020;1195:49-56. https://doi.org/10.1007/978-3-030-32633-3_8.
  71. Zizza A, Panico A, Grassi T, Recchia V, Grima P, De Giglio O, Bagordo F. Is telomere length in buccal or salivary cells a useful biomarker of exposure to air pollution? A review. Mutat Res Genet Toxicol Environ Mutagen. 2022 Nov-Dec;883-884:503561. https://doi.org/10.1016/j.mrgentox.
  72. MyakotnykhVS, SidenkovaAP, BazarnyyVV, MelnikAA, UrazaevaAT, KhilyukDA. Diagnostic possibilities of studying buccal epithelium in the elderly with cognitive impairments. Siberian Herald of Psychiatry and Addiction Psychiatry. 2022;1(114):40-45. https://doi.org/10.26617/1810-3111-2022-1(114)-40-45 (in Russian).
  73. Zhang X, Zhong M, Li Y, Wang H, Xi G, Wang F, Cheng C, Shi Y. Oral microbiota and central nervous system diseases: A review. Neuroprotection. 2025 Feb 9;3(1):79-94. https://doi.org/10.1002/nep3.75.
  74. Jain AP, Sathe G. Proteomics landscape of Alzheimer’s disease. Proteomes. 2021 Mar 10;9(1):13. https://doi.org/10.3390/proteomes9010013. PMID: 33801961; PMCID: PMC8005944.
  75. Sukumaran P, Bahardin AA, Abdul Razak LH., Senik MH. Application of proteomics in Alzheimer’s disease: A mini review. Malaysian J Medicine and Health Sciences. 2023;19(5), 317-330. https://doi.org/10.47836/mjmhs.v19i5.732.